Blue Crest Capital Management LTD Adamis Pharmaceuticals Corp Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.26 - $2.23 $61,362 - $108,601	-48,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.02 - $3.22 $98,374 - $156,814	48,700 New	48,700 $103,000
Q2 2018 Aug 14, 2018	SELL	$3.2 - $4.7 $65,920 - $96,820	-20,600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.55 - $4.85 $52,529 - $99,909	20,600 New	20,600 $72,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.